| JYSB2100020 | 依那西普注射液 | etanercept | Injection | Biological Products | Supplementary Application | 2021-01-16 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | In Review | 2022-01-19 | view |
| JXSS2000001 | 注射用伊珠单抗奥唑米星 | inotuzumab ozogamicin | Lyophilized | Biological Products | Import Drug Application | 2020-01-22 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Approval Completed-Pending Certificated | 2021-12-20 | view |
| JXHS2000102 | 硫酸艾沙康唑胶囊 | isavuconazonium sulfate | Capsule | Chemical Drugs(5.1) | Import Drug Application | 2020-07-04 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-12-17 | view |
| JXSS1900048 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2019-08-22 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-12-15 | view |
| JXSS1900047 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2019-08-22 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-12-15 | view |
| JXSS1900050 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2019-08-22 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-12-15 | view |
| JXSS1900049 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2019-08-22 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-12-15 | view |
| JYHB2001699 | 达肝素钠注射液 | dalteparin sodium | Injection | Chemical Drugs | Supplementary Application | 2020-09-07 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-11-15 | view |
| JYHB2001704 | 达肝素钠注射液 | dalteparin sodium | Injection | Chemical Drugs | Supplementary Application | 2020-09-07 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-11-15 | view |
| JYHB2001698 | 达肝素钠注射液 | dalteparin sodium | Injection | Chemical Drugs | Supplementary Application | 2020-09-07 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-11-15 | view |
| JYHB2001703 | 达肝素钠注射液 | dalteparin sodium | Injection | Chemical Drugs | Supplementary Application | 2020-09-07 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-11-15 | view |
| JYHB2001702 | 达肝素钠注射液 | dalteparin sodium | Injection | Chemical Drugs | Supplementary Application | 2020-09-07 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-11-15 | view |
| JYHB2001701 | 达肝素钠注射液 | dalteparin sodium | Injection | Chemical Drugs | Supplementary Application | 2020-09-07 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-11-15 | view |
| JYHB2001706 | 达肝素钠注射液 | dalteparin sodium | Injection | Chemical Drugs | Supplementary Application | 2020-09-07 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-11-15 | view |
| JYHB2001700 | 达肝素钠注射液 | dalteparin sodium | Injection | Chemical Drugs | Supplementary Application | 2020-09-07 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-11-15 | view |
| JYHB2001705 | 达肝素钠注射液 | dalteparin sodium | Injection | Chemical Drugs | Supplementary Application | 2020-09-07 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-11-15 | view |
| JYHZ2100028 | 注射用氨苄西林钠舒巴坦钠 | ampicillin sodium;sulbactam sodium | Lyophilized | Chemical Drugs | License Renew | 2021-02-11 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-11-04 | view |
| JYSB2000300 | 依那西普注射液 | etanercept | Injection | Biological Products | Supplementary Application | 2020-07-04 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-10-27 | view |
| JYSB2000299 | 依那西普注射液 | etanercept | Injection | Biological Products | Supplementary Application | 2020-07-04 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-10-27 | view |
| JYSZ2100004 | 13价肺炎球菌多糖结合疫苗 | 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | Injection | Biological Products | License Renew | 2021-02-06 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-10-20 | view |
